The 20 Best Angiosarcoma Doctors near Teaneck, NJ

Sandra D'angelo is an Oncologist in New York, New York. Dr. D'angelo is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Synovial Sarcoma, Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.

Donna Mcnamara is an Oncologist in Hackensack, New Jersey. Dr. Mcnamara is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, and Angiosarcoma.

Deena Graham is an Oncologist in Hackensack, New Jersey. Dr. Graham is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Gastrostomy.

Stanley Waintraub is an Oncologist in Hackensack, New Jersey. Dr. Waintraub is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Andrew Pecora is an Oncologist in Hackensack, New Jersey. Dr. Pecora is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Epithelioid Sarcoma, Melanoma, Adult Soft Tissue Sarcoma, Bone Marrow Transplant, and Tissue Biopsy.

Lisa Sclafani is a General Surgeon in New York, New York. Dr. Sclafani is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy.

William Tap is an Oncologist in New York, New York. Dr. Tap is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization. Dr. Tap is currently accepting new patients.

Robert Maki is an Oncologist in New York, New York. Dr. Maki is rated as an Elite provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Gastrointestinal Stromal Tumor, and Undifferentiated Pleomorphic Sarcoma. Dr. Maki is currently accepting new patients.

Deborah Axelrod is a Surgical Oncologist and a General Surgeon in New York, New York. Dr. Axelrod has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Fibrocystic Breast Disease, Breast Infection, Mastectomy, and Lymphadenectomy.

Frank Ciminello is a Plastic Surgeon in Maywood, New Jersey. Dr. Ciminello is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Liposarcoma, Mesenchymoma, Rhabdomyosarcoma Embryonal, Fibrosarcoma, and Bone Graft. Dr. Ciminello is currently accepting new patients.

Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Vulvectomy, and Salpingo-Oophorectomy.

Katherine D. Crew, M.D., M.S. is an the Avon Products Foundation Professor of Medicine and Epidemiology at the NewYork-Presbyterian/Columbia University Medical Center, co-associate director for education and training and co-director of the Cancer Research Training and Education Core (CRTEC) at the Herbert Irving Comprehensive Cancer Center (HICCC). In addition to treating patients with breast cancer and women at high-risk for breast cancer, Dr. Crew has a long-standing interest and background in the design of clinical trials and observational studies in breast cancer prevention and survivorship.She serves as the Director of the Clinical Breast Cancer Prevention Program at Columbia University and Executive Officer for the SWOG Prevention, Screening, and Surveillance and Cancer Care Delivery Committees. She is a member of multiple national consortia and societies in oncology, including the American Association for Cancer Research and American Society of Clinical Oncology, and is an editorial board member of the Journal of Clinical Oncology. Dr. Crew received her undergraduate B.S. in Biochemistry from Brown University, where she graduated Magna Cum Laude. She received her M.D. from Columbia University College of Physicians and Surgeons and her M.S. from Columbia University School of Public Health. She completed her Internal Medicine residency and Medical Oncology fellowship at NewYork-Presbyterian/Columbia University Medical Center. Dr. Crew is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy.

Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon’s Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor. Dr. Taback is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Breast Cancer, Melanoma, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.

Paul L. Baron, MD, is Chief of breast surgery and Director of the breast cancer program at Lenox Hill Hospital. An accomplished breast surgical oncologist, Dr. Baron specializes in high risk patients and oncoplastic surgery. His goals are to oversee the expansion and enhancement of the hospital s breast surgery services and it's multidisciplinary breast cancer program. The Breast Cancer Center of the Northwell Health Cancer Institute, is one of the largest oncology programs in the New York metro area.Throughout his career, Dr. Baron has actively engaged in advancing the field of oncology. He has published more than 120 articles and abstracts on various cancer-related topics and has been invited to speak at more than 60 national conferences. He has received more than $3.3 million in grant funding for medical research from such high-profile sources as the American Cancer Society and the Department of Defense and holds two patents in the area of cancer diagnosis and treatment. He is affiliated with numerous distinguished professional societies, including The American College of Surgeons, The Society of Surgical Oncology and The American Society of Breast Surgeons, where he serves on the board of directors. He also serves on the Board of Directors of the National Accreditation Program for Breast Centers (NAPBC).Dr. Baron earned both his undergraduate and medical degrees from Boston University's six-year medical program. He completed his internship and residency in general surgery at the Medical College of Virginia, where he served as chief surgery resident during his final year. He subsequently pursued a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center and was honored with the American Cancer Society s Clinical Oncology Fellowship Award for his work. Dr. Baron is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Lymphadenectomy.

Jocelyn Wozney is a Hematologist and an Oncologist in New York, New York. Dr. Wozney is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Familial Pancreatic Cancer, and Bone Marrow Aspiration.

Silvia Formenti is a Radiation Oncologist in New York, New York. Dr. Formenti is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Triple-Negative Breast Cancer, and Intraductal Papilloma.

My research is focused on breast cancer management, and on care delivery and support for breast cancer patients. Dr. Makower is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Sheldon Marc Feldman, MD, is Chief, Breast Surgery and Breast Surgical Oncology, Professor, Surgery and Director, Breast Cancer Services at Montefiore Einstein. His clinical focus includes breast cancer, oncoplastic surgery with an emphasis on optimizing breast conservation, nipple-sparing mastectomy, minimally invasive diagnosis and treatment, intraoperative radiation, targeted tumor ablation, lymphedema prevention, and complementary integrative holistic care with an emphasis on physician-patient communication. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Intraductal Papilloma, Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy.

Jesus Anampa Mesias, MD is a medical oncologist at Montefiore Einstein Comprehensive Cancer Center and a member of its Cancer Therapeutics Research Program focused on identifying new treatment targets and novel cancer therapeutics. He is fluent in Spanish and enjoys participating in bilingual community activities about cancer prevention and treatment in our community. Dr. Mesias is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer.

Sun Young Oh, MD, is an Oncologist and Assistant Professor, Oncology and Medicine at Montefiore Einstein. Her clinical focus is on medical oncology and the systemic treatment of breast cancer. Dr. Oh is rated as a Distinguished provider by MediFind in the treatment of Angiosarcoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.